Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · Real-Time Price · USD
7.63
-0.55 (-6.72%)
At close: Feb 21, 2025, 4:00 PM
7.64
+0.01 (0.13%)
After-hours: Feb 21, 2025, 7:36 PM EST
Mind Medicine (MindMed) Employees
Mind Medicine (MindMed) had 57 employees as of December 31, 2023. The number of employees increased by 9 or 18.75% compared to the previous year.
Employees
57
Change (1Y)
9
Growth (1Y)
18.75%
Revenue / Employee
n/a
Profits / Employee
-$1,715,825
Market Cap
559.52M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 57 | 9 | 18.75% |
Dec 31, 2022 | 48 | 7 | 17.07% |
Dec 31, 2021 | 41 | 19 | 86.36% |
Dec 31, 2020 | 22 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
MNMD News
- 2 days ago - MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 - Business Wire
- 18 days ago - MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire
- 23 days ago - MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder - Business Wire
- 2 months ago - MindMed to Be Added to the Nasdaq Biotechnology Index - Business Wire
- 2 months ago - MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD) - Business Wire
- 2 months ago - MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress - Business Wire
- 2 months ago - MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD) - Business Wire
- 2 months ago - MindMed Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy - Business Wire